Artificial intelligence (AI) has been the word of 2023, but aside from the promises, what are the realities of its practical implementation in the life sciences setting?
Novo Nordisk’s breakneck sales growth has continued in the first quarter of this year with a 24% increase that was helped by a doubling in turnover of obesity blockbuster Wegovy
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.